New to site?


Login

Lost password? (X)

Already have an account?


Signup

(X)
Farooq

Bristol-Myers Squibb awards “Golden Tickets” for LabCentral to Carmine Therapeutics, STIMIT

HomeINDUSTRY NEWSBristol-Myers Squibb awards “Golden Tickets” for LabCentral to Carmine Therapeutics, STIMIT
31
Oct
Bristol-Myers Squibb awards “Golden Tickets” for LabCentral to Carmine Therapeutics, STIMIT

Bristol-Myers SquibbBristol-Myers Squibb Company (NYSE:BMY) and LabCentral, an innovative, shared laboratory space designed as a launchpad for life sciences and biotech startups, today announced that Carmine Therapeutics and STIMIT are the winners of Bristol-Myers Squibb's 2019 Golden Tickets for LabCentral.Original Article

Tags:

    Related Posts
    Leave A Comment

    Leave A Comment